Financial toxicity differences between chemical versus surgical androgen deprivation therapy
Transl Androl Urol
.
2022 Oct;11(10):1365-1367.
doi: 10.21037/tau-22-588.
Authors
Jeanny B Aragon-Ching
1
,
Inger L Rosner
2
Affiliations
1
GU Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA, USA.
2
Department of Urology, Inova Schar Cancer Institute, Fairfax, VA, USA.
PMID:
36386267
PMCID:
PMC9641061
DOI:
10.21037/tau-22-588
No abstract available
Publication types
Editorial
Comment